Search results
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 2 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoLexicon Pharmaceuticals has chosen clinical trial solutions provider Medidata to help advance the ...
...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...
WTNH-TV New Haven· 7 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development...
Study Reveals Worse Clinical Outcomes in Breast Ca | Newswise
Newswise· 16 hours agoSecondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Pharmaceutical Technology via Yahoo Finance· 11 hours agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
J&J’s seltorexant meets all endpoints in Phase III MDD trial
Clinical Trials Arena via Yahoo Finance· 11 hours agoThe MDD therapeutics market is projected to grow to $9.6bn by 2029, driven by an increase in the...
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 12 hours agoBiohaven has dosed the first subject in its Phase I/II clinical trial of BHV-1510, a trophoblast...
Does Medicare Part D cover prescriptions for clinical trials?
Las Vegas Review-Journal· 6 hours agoExploring Part D and prescription drugs is one of the most important Medicare topics. Lincoln, you...
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoSOTIO Biotech has dosed the first subject in its Phase I clinical trial VICTORIA-01 to assess the...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 49 minutes agoViking Therapeutics to Participate at Upcoming Investor Conferences PR Newswire SAN DIEGO, May 30, 2024 SAN DIEGO, May 30, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: ...
